Eribulin

ATC Code L01XX41

Eribulin

Definition

An analogue of halichondrin B, a substance derived from a marine sponge (Lissodendoryx sp.) with antineoplastic activity. Eribulin binds to the vinca domain of tubulin and inhibits the polymerization of tubulin and the assembly of microtubules, resulting in inhibition of mitotic spindle assembly, induction of cell cycle arrest at G2/M phase, and, potentially, tumor regression.

Also known as 2-(3-Amino-2-hydroxypropyl)hexacosahydro-3-methoxy-26-methyl-20,27-bis(methylene)11,15-18,21-24,28-triepoxy-7,9-ethano-12,15-methano-9H,15H-furo(3,2-i)furo(2',3'-5,6)pyrano(4,3-b)(1,4)dioxacyclopentacosin-5-(4H)-one, E 7389, E-7389, ER 086526, ER-086526, ER086526, ERIBULIN — per NCIT

Also identified as

Indications

Disease Relation Source
Breast neoplasm may treat MEDRT · Public domain (U.S. Government work)
Liposarcoma may treat MEDRT · Public domain (U.S. Government work)